Browsing Tag
American College of Rheumatology
2 posts
Beeline Medicines advances afimetoran toward pivotal lupus trials after strong Phase 2 results
Beeline Medicines' afimetoran trial success puts its $426.3 million-backed lupus strategy in focus. Explore the pivotal plans and risks ahead.
Interpreting the RESET-RA 12-month outcomes: What matters for clinical decision-making
Find out how SetPoint Medical’s neuroimmune modulation therapy is reshaping rheumatoid arthritis treatment with sustained 12-month clinical results.